And still showing a drawing of a gold source with a shape and depth to be determined. Where are the assays for the deep hole????? Not good enough to publish and from what I can glean and read between the lines in their announcements, they found nothing of any significance and certainly no data to increase the gold resource as the illustrious MD has touted in past announcements. A nothing presentation, all gunna stuff. they need to start proving they can produce, I mean how long has it been now floundering along with a very tiny production level.
- Forums
- ASX - By Stock
- remaining positive
And still showing a drawing of a gold source with a shape and...
Featured News
Add CTO (ASX) to my watchlist
|
|||||
Last
0.4¢ |
Change
-0.001(20.0%) |
Mkt cap ! $12M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $20K | 5M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 10248750 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 4174709 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 10248750 | 0.004 |
14 | 10204022 | 0.003 |
5 | 4895025 | 0.002 |
9 | 12802988 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 4174709 | 8 |
0.006 | 2260000 | 4 |
0.007 | 1229758 | 3 |
0.008 | 3593671 | 6 |
0.009 | 1846323 | 4 |
Last trade - 14.23pm 09/08/2024 (20 minute delay) ? |
Featured News
BOE
Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan
NEU
Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
CTO (ASX) Chart |